To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Clinical trial NCT03291418 · COMPLETED
Trial details
- NCT number
- NCT03291418
- Sponsor
- Antibe Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2018-03-31
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.